Managing patients with hematological malignancies during COVID-19 pandemic

References

• Sahu KK, Kumar R. Current perspective on pandemic of COVID-19 in the United States. J Fam Med Prim Care. 2020Apr 1;9(4):1784.
   PubMedGoogle Scholar
• Coronavirus Update (Live): 8,228,019 cases and 444,442 deaths from COVID-19 virus pandemic - worldometer [Internet]. [ cited 2020 Jun 17]. Available from: https://www.worldometers.info/coronavirus/#countries
   Google Scholar
• Sahu KK, Mishra AK, Lal A. Trajectory of the COVID-19 pandemic: chasing a moving target. Ann Transl Med. 2020 May 30;8(11):694.
   PubMed Web of Science ®Google Scholar
• Cascella M, Rajnik M, Cuomo A, et al. Features, evaluation and treatment coronavirus (COVID-19). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 cited 2020 Jun 16. Available from: http://www.ncbi.nlm.nih.gov/books/NBK554776/
   Google Scholar
• Cruz MC, Flores JAS, Paule JR, et al. Adapting to the contemporary normal in cancer management and workflow during COVID-19 situation in the Philippines: multi-cancer center collaborative approach. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2020 Jun 13;150:70–72.
   Google Scholar
• Trehan A, Jain R, Bansal D. Oncology care in a lower middle-income country during the COVID-19 pandemic. Pediatr Blood Cancer. 2020 Jun 15:e28438.
   PubMed Web of Science ®Google Scholar
• Sahu KK, Siddiqui AD, Cerny J. Managing sickle cell patients with COVID-19 infection: the need to pool our collective experience. Br J Haematol. 2020 May 23. DOI:10.1111/bjh.16880.
   PubMed Web of Science ®Google Scholar
• Sahu KK, Mishra AK, Lal A. Coronavirus disease-2019: an update on third coronavirus outbreak of 21st century. QJM Mon J Assoc Physicians. 2020 01;113(5):384–386.
   PubMed Web of Science ®Google Scholar
• Lal A, Mishra AK, Sahu KK. CT chest findings in coronavirus disease-19 (COVID-19). J Formos Med Assoc. 2020;119(5):1000–1001.
   PubMed Web of Science ®Google Scholar
• Mishra AK, Sahu KK, Lal A, et al. Patterns of heart injury in COVID - 19 and relation to outcome. J Med Virol. 2020 Apr 8. DOI:10.1002/jmv.25847.
   Web of Science ®Google Scholar
• Alaskar A, Bosaeed M, Rehan H, et al. Middle East Respiratory Syndrome (MERS) infection in hematological and oncological patients: a case series from a tertiary care center in Saudi Arabia. Blood. 2019 Nov 13;134(Supplement_1):5871.
   Google Scholar
• Ángeles-Sistac D, Martin-Onraet A, Cornejo-Juárez P, et al. Influenza in patients with cancer after 2009 pandemic AH1N1: an 8-year follow-up study in Mexico. Influenza Other Respir Viruses. 2020;14(2):196–203.
   PubMed Web of Science ®Google Scholar
• Chen Y-M, Perng R-P, Chu H, et al. Impact of severe acute respiratory syndrome on the status of lung cancer chemotherapy patients and a correlation of the signs and symptoms. Lung Cancer Amst Neth. 2004 Jul;45(1):39–43.
   PubMed Web of Science ®Google Scholar
• Wu J, Liu J, Zhao X, et al. Clinical characteristics of imported cases of COVID-19 in Jiangsu province: a multicenter descriptive study. Clin Infect Dis Off Publ Infect Dis Soc Am. 2020 Feb 29:ciaa199.
   Google Scholar
• Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335–337.
   PubMed Web of Science ®Google Scholar
• Gavillet M, Carr Klappert J, Spertini O, et al. Acute leukemia in the time of COVID-19. Leuk Res. 2020 Mar 26;92:106353.
   PubMed Web of Science ®Google Scholar
• COVID-19 Lessons from Wuhan. Hematology.org [Internet]. [ cited 2020 Jun 16]. Available from: https://www.hematology.org/covid-19/covid-19-lessons-from-wuhan
   Google Scholar
• Paul S, Rausch CR, Jain N, et al. Treating leukemia in the time of COVID-19. Acta Haematol. 2020 May 11:1–13. DOI:10.1159/000508199.
   PubMed Web of Science ®Google Scholar
• He W, Chen L, Chen L, et al. COVID-19 in persons with haematological cancers. Leukemia. 2020;34(6):1637–1645.
   PubMed Web of Science ®Google Scholar
• Martín-Moro F, Marquet J, Piris M, et al. Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies. Br J Haematol. 2020 May 7. DOI:10.1111/bjh.16801.
   PubMed Web of Science ®Google Scholar
• ESMO. Cancer patient management during the COVID-19 Pandemic [Internet]. [ cited 2020 Jun 16]. Available from: https://www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic
   Google Scholar
• Sahu KK, Siddiqui AD. From hematologist’s desk: the effect of COVID-19 on the blood system [published online ahead of print, 2020 May 1]. Am J Hematol. 2020. DOI:10.1002/ajh.25849
   PubMed Web of Science ®Google Scholar
• Mishra AK, Sahu KK, Kaul S, et al. Dasatinib induced pleuro-pericardial effusion. Acta Bio-Medica Atenei Parm. 2020 19;91(1):142–143.
   PubMedGoogle Scholar
• Parikh SA, Rabe KG, Kay NE, et al. Chronic lymphocytic leukemia in young (≤ 55 years) patients: a comprehensive analysis of prognostic factors and outcomes. Haematologica. 2014 Jan;99(1):140–147.
   PubMed Web of Science ®Google Scholar
• Treon SP, Castillo JJ, Skarbnik AP, et al. The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients. Blood. 2020 May 21;135(21):1912–1915.
   PubMed Web of Science ®Google Scholar
• Pollyea DA, Amaya M, Strati P, et al. Venetoclax for AML: changing the treatment paradigm. Blood Adv. 2019 23;3(24):4326–4335.
   PubMed Web of Science ®Google Scholar
• Hamadani M, Zhang M-J, Tang X-Y, et al. Graft cryopreservation does not impact overall survival after allogeneic hematopoietic cell transplantation using post-transplantation cyclophosphamide for graft-versus-host disease prophylaxis. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2020 Apr 10;26:1312–1317.
   Google Scholar
• Managing donor collections during the COVID-19 pandemic [Internet]. Be The Match BioTherapies; 2020 cited 2020 Jun 16. Available from: https://bethematchbiotherapies.com/cell-lines-blog/donor-collections-covid-19/
   Google Scholar
• Sahu KK, Jindal V, Siddiqui AD, et al. Facing COVID-19 in the hematopoietic cell transplant setting: a new challenge for transplantation physicians. Blood Cells Mol Dis. 2020 Jul 83;83:102439.
   PubMed Web of Science ®Google Scholar
• Sahu KK, Siddiqui AD, Cerny J. COVID-19 pandemic and impact on hematopoietic stem cell transplantation. Bone Marrow Transplant. 2020 May 4. DOI:10.1038/s41409-020-0913-6.
   PubMedGoogle Scholar
• II P. COVID-19 and EBMT recommendations for patients with hematological malignancies [Internet]. [ cited 2020 Jun 16]. Available from: https://gvhdhub.com/medical-information/covid-19-and-ebmt-recommendations-for-patients-with-hematological-malignancies
   Google Scholar
• Coronavirus - SARS-CoV-2 & COVID-19 - WMDA donor medical suitability recommendations - share [Internet]. [ cited 2020 Jun 16]. Available from: https://share.wmda.info/pages/viewpage.action?pageId=344866320#/
   Google Scholar
• Ogonek J, Kralj Juric M, Ghimire S, et al. Immune reconstitution after allogeneic hematopoietic stem cell transplantation. Front Immunol. 2016;7:507.
   PubMed Web of Science ®Google Scholar
• Sahu KK, Mahagaokar K, Patel B, et al. Strongyloides stercoralis hyperinfection syndrome in mantle cell lymphoma in post-transplant setting. Ann Hematol. 2020 May 6. DOI:10.1007/s00277-020-04049-8.
   Web of Science ®Google Scholar
• Sahu KK, Mishra AK, Martin K, et al. COVID-19 and clinical mimics. Correct diagnosis is the key to appropriate therapy. Monaldi Arch Chest Dis Arch Monaldi Mal Torace. 2020 May 6;90(2).
   Web of Science ®Google Scholar
• Ljungman P, Mikulska M, de la Camara R, et al. The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy. Bone Marrow Transplant. 2020 May 13:1–6. Ahead of print.
   PubMed Web of Science ®Google Scholar
• Szer J, Weisdorf D, Querol S, et al. The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage. Bone Marrow Transplant. 2020 Mar 23. DOI:10.1038/s41409-020-0873-x.
   Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course, and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054–1062.
   PubMed Web of Science ®Google Scholar
• Sahu KK, Kumar R. Preventive and treatment strategies of COVID-19: from community to clinical trials. J Fam Med Prim Care. 2020 May 1;9(5):2149.
   PubMedGoogle Scholar
• Pagano MB, Hess JR, Tsang HC, et al. Prepare to adapt blood supply and transfusion support during the first 2 weeks of the 2019 novel coronavirus (COVID-19) pandemic affecting Washington State. Transfusion (Paris). 2020;60(5):908–911.
   PubMed Web of Science ®Google Scholar
• Sahu KK, Jindal V, Siddiqui AD, et al. Convalescent plasma therapy: a passive therapy for an aggressive COVID-19. J Med Virol. 2020 May 21. DOI:10.1002/jmv.26047.
   Web of Science ®Google Scholar
• Dickerson D. Seven tips to manage your mental health and well-being during the COVID-19 outbreak [published online ahead of print, 2020 Mar 26]. Nature. 2020. DOI:10.1038/d41586-020-00933-5
   PubMedGoogle Scholar
• Ueda M, Martins R, Hendrie PC, et al. Managing cancer care during the COVID-19 pandemic: agility and collaboration toward a common goal. J Natl Compr Cancer Netw JNCCN. 2020 Mar:1–4.
   PubMed Web of Science ®Google Scholar
• Sahu KK, Mishra AK, Lal A, et al. India fights back: COVID-19 pandemic. Heart Lung J Crit Care. 2020 Apr 23. DOI:10.1016/j.hrtlng.2020.04.014.
   Web of Science ®Google Scholar
• Jindal V, Sahu KK, Gaikazian S, et al. Cancer treatment during COVID-19 pandemic. Med Oncol Northwood Lond Engl. 2020 May 29;37(7):58.
   PubMed Web of Science ®Google Scholar
• Waterhouse DM, Harvey RD, Hurley P, et al. Early impact of COVID-19 on the conduct of oncology clinical trials and long-term opportunities for transformation: findings from an American Society of clinical oncology survey. JCO Oncol Pract. 2020 May 12:OP2000275. DOI:10.1200/OP.20.00275.
   Google Scholar
• He Y, Lin Z, Tang D, et al. Strategic plan for management of COVID-19 in paediatric haematology and oncology departments. Lancet Haematol. 2020 May;7(5):e359–62.
   PubMed Web of Science ®Google Scholar
• ESMO-CoCARE Registry | ESMO [Internet]. [ cited 2020 Jun 17]. Available from: https://www.esmo.org/covid-19-and-cancer/collaborating-on-registries-studies-and-surveys/esmo-cocare-registry
   Google Scholar
• Sahu KK, Jindal V, Siddiqui AD. Managing COVID-19 in patients with cancer: a double blow for oncologists. JCO Oncol Pract. 2020;16(5):223–225.
   PubMedGoogle Scholar